← Back to guidelines
Orthopedics3 papers

Malignant sacral teratoma

Last edited:

Overview

Malignant sacral teratomas are rare and aggressive tumors that arise from the sacrococcygeal region, often presenting in adulthood despite their embryonic origin. These tumors can harbor various malignant components, including germ cell tumors (such as teratocarcinoma or yolk sac tumors) and somatic malignancies (like rhabdomyosarcoma or osteosarcoma). Due to their complex histological nature and potential for rapid growth, malignant sacral teratomas pose significant diagnostic and therapeutic challenges. Early diagnosis and comprehensive surgical intervention are crucial for improving patient outcomes. The management typically involves en bloc sacrectomy, but the choice of reconstruction method significantly influences postoperative stability and complication rates.

Diagnosis

Diagnosing malignant sacral teratomas requires a multidisciplinary approach, integrating clinical evaluation, imaging studies, and histopathological analysis. Patients often present with nonspecific symptoms such as lower back pain, neurological deficits, or palpable masses. Imaging modalities, particularly MRI and CT scans, play pivotal roles in delineating the extent of the tumor and assessing its relationship with surrounding structures. MRI is particularly valuable for characterizing the heterogeneous composition of teratomas and identifying any neural involvement. CT scans provide detailed information about bone involvement and help in planning surgical approaches.

Histopathological examination is definitive, revealing the presence of multiple tissue types characteristic of teratomas, alongside malignant elements. Immunohistochemistry and molecular studies may further classify the tumor subtypes, guiding prognosis and treatment strategies. Early suspicion and prompt referral to specialized centers with expertise in managing complex sacral tumors are essential for optimal outcomes.

Management

Surgical Management

The cornerstone of managing malignant sacral teratomas is radical surgical resection, typically achieved through en bloc sacrectomy. This extensive procedure aims to remove the tumor along with the affected sacral bone segments to minimize local recurrence. A retrospective study involving 51 patients [PMID:35007788] underscores the high incidence of surgical site infections (SSIs), affecting 57% of cases, highlighting the critical importance of stringent infection control protocols. These protocols should include meticulous surgical technique, appropriate prophylactic antibiotics (e.g., broad-spectrum coverage tailored to local resistance patterns), and vigilant postoperative care to prevent infections.

#### Reconstruction Techniques

Post-sacrectomy reconstruction aims to restore biomechanical stability and function. Biomechanical testing has shown that constructs using L5-iliac cage struts (CSs) and S-1 body replacement expandable cages (EC) exhibit significantly reduced flexion-extension range of motion ratios compared to interiliac femoral strut allografts (FSA) [PMID:24460580]. Specifically, CSs had a ratio of 0.37 ± 0.12, ECs 0.29 ± 0.14, while FSA maintained a ratio of 1.22 ± 0.60. This suggests that femoral strut allografts may offer superior stability, potentially reducing complications such as implant loosening and graft migration. However, the choice of reconstruction should balance biomechanical stability with patient-specific factors like age, activity level, and overall health.

Single-Stage Total Sacrectomy

Single-stage total sacrectomy has been demonstrated as a feasible approach in small case series, such as the study involving nine patients with various malignant sacral tumors [PMID:23392420]. This approach consolidates the surgical intervention, reducing the need for multiple surgeries and associated risks. However, it necessitates meticulous surgical planning and execution to manage complex anatomical challenges, particularly concerning neural structures. Notably, in this series, bilateral sacrifice of the S1 nerve root occurred in 8 out of 9 patients, indicating a significant functional risk that must be carefully communicated to patients preoperatively and managed with appropriate rehabilitation strategies post-surgery.

Key Recommendations

  • Infection Prevention: Implement strict aseptic techniques, use prophylactic antibiotics tailored to local resistance patterns, and monitor closely for signs of infection postoperatively.
  • Reconstruction Choice: Consider femoral strut allografts for enhanced biomechanical stability, especially in younger, more active patients.
  • Neural Preservation: Whenever possible, preserve sacral nerve roots to minimize postoperative neurological deficits; discuss potential risks and rehabilitation needs with patients.
  • Multidisciplinary Approach: Engage orthopedic surgeons, neurosurgeons, infectious disease specialists, and rehabilitation specialists to optimize patient care.
  • Complications

    Surgical Site Infections

    Surgical site infections (SSIs) represent a significant complication following en bloc sacrectomy for malignant sacral teratomas, as evidenced by the 57% incidence rate in a study of 51 patients [PMID:35007788]. These infections can be categorized into deep infections (7 cases) and organ/space infections (22 cases), typically manifesting around 13.2 days post-surgery. Early recognition through vigilant monitoring (e.g., regular wound assessments, laboratory markers like CRP and WBC counts) is crucial. Management often involves targeted antibiotic therapy based on culture and sensitivity results, along with surgical debridement if necessary. Enhanced postoperative care, including meticulous wound management and early mobilization, can mitigate infection risks.

    Biomechanical Instability

    The use of cage struts and expandable cages in reconstruction has been associated with poorer biomechanical stability compared to femoral strut allografts [PMID:24460580]. This instability increases the risk of complications such as implant loosening and graft migration, which can lead to chronic pain, functional impairment, and the need for revision surgeries. Patients undergoing these reconstructive methods should be closely monitored for signs of instability, including gait abnormalities, pain, and radiographic changes. Regular follow-up assessments, ideally every 3-6 months initially, are recommended to detect early signs of complications and intervene promptly.

    Neurological Deficits

    Neurological complications, particularly involving the sacral nerve roots, are significant concerns in sacrectomy procedures. In a series of nine patients [PMID:23392420], bilateral sacrifice of the S1 nerve root occurred in 8 patients, highlighting the functional risks associated with extensive sacral resections. Postoperative management should include comprehensive neurological assessments and tailored rehabilitation programs to address deficits such as bowel/bladder dysfunction, sexual dysfunction, and lower extremity motor/sensory impairments. Multidisciplinary rehabilitation teams, including physiatrists, physical therapists, and urologists, are essential in optimizing patient recovery and quality of life.

    Prognosis & Follow-Up

    Survival Outcomes

    The impact of SSIs on survival outcomes is profound, as demonstrated by Kaplan-Meier curve analyses in the study of 51 patients [PMID:35007788]. Infected patients exhibited significantly poorer overall and disease-free survival rates compared to their non-infected counterparts. This underscores the necessity for rigorous postoperative infection surveillance and management to improve long-term outcomes. Enhanced follow-up protocols, including regular imaging and clinical assessments, are crucial for early detection and management of recurrent disease or complications.

    Recurrence Rates

    Local recurrence remains a critical concern, with a reported incidence of 22% within the follow-up period of 11 to 35 months in a series of nine patients [PMID:23392420]. Given this risk, patients should undergo regular imaging studies (e.g., MRI and CT scans) at intervals of 6-12 months initially, tapering based on clinical stability. Additionally, clinical evaluations focusing on symptom recurrence and functional status are essential to detect early signs of recurrence or new malignancies.

    Follow-Up Recommendations

  • Infection Monitoring: Conduct regular wound assessments and laboratory tests (CRP, WBC) every 2-4 weeks postoperatively, transitioning to monthly visits as healing progresses.
  • Biomechanical Stability: Schedule radiographic evaluations (X-rays, CT scans) every 3-6 months initially, focusing on implant integrity and bone healing.
  • Neurological Function: Perform detailed neurological assessments at 1, 3, 6, and 12 months postoperatively, with subsequent evaluations based on patient recovery trajectory.
  • Recurrence Surveillance: Implement imaging follow-ups (MRI, CT) every 6-12 months for the first 2-3 years, adjusting based on clinical stability and initial recurrence risk stratification.
  • By adhering to these comprehensive management strategies and vigilant follow-up protocols, clinicians can optimize outcomes for patients with malignant sacral teratomas, balancing the risks of extensive surgical interventions with the potential for long-term survival and functional recovery.

    References

    1 Marmouset D, Haseny B, Dukan R, Saint-Etienne A, Missenard G, Court C et al.. Characteristics, survivals and risk factors of surgical site infections after En Bloc sacrectomy for primary malignant sacral tumors at a single center. Orthopaedics & traumatology, surgery & research : OTSR 2022. link 2 Clark AJ, Tang JA, Leasure JM, Ivan ME, Kondrashov D, Buckley JM et al.. Gait-simulating fatigue loading analysis and sagittal alignment failure of spinal pelvic reconstruction after total sacrectomy: comparison of 3 techniques. Journal of neurosurgery. Spine 2014. link 3 Guo W, Tang X, Zang J, Ji T. One-stage total en bloc sacrectomy: a novel technique and report of 9 cases. Spine 2013. link

    Original source

    1. [1]
      Characteristics, survivals and risk factors of surgical site infections after En Bloc sacrectomy for primary malignant sacral tumors at a single center.Marmouset D, Haseny B, Dukan R, Saint-Etienne A, Missenard G, Court C et al. Orthopaedics & traumatology, surgery & research : OTSR (2022)
    2. [2]
      Gait-simulating fatigue loading analysis and sagittal alignment failure of spinal pelvic reconstruction after total sacrectomy: comparison of 3 techniques.Clark AJ, Tang JA, Leasure JM, Ivan ME, Kondrashov D, Buckley JM et al. Journal of neurosurgery. Spine (2014)
    3. [3]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG